Xeris Biopharma Inc.

XERS | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.78

-$0.02 (-0.23%)

Sep 22, 2026, 10:52 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	554K	-54.84M	-62.26M	-94.66M	-122.73M	-91.14M
Depreciation & Amortization	12.16M	12.63M	13.16M	12.67M	1.88M	1.47M
Stock-Based Compensation	22.37M	18.36M	10.72M	12.16M	11.38M	8.27M
Other Working Capital	19.63M	10.79M	9.92M	-9.99M	19.98M	7.01M
Other Non-Cash Items	3.91M	-2.05M	-1.1M	3.52M	3.5M	39K
Deferred Income Tax	n/a	-2.27M	-1.25M	-1.42M	-1.42M	1.12M
Change in Working Capital	-10.36M	-8.82M	-6.29M	-35.15M	11.85M	-312K
Operating Cash Flow	28.63M	-36.98M	-47.02M	-102.89M	-95.54M	-80.56M
Capital Expenditures	-696K	-868K	-2.26M	-524K	-524K	-1.09M
Cash Acquisitions	n/a	n/a	n/a	n/a	38.47M	n/a
Purchase of Investments	n/a	-34.49M	-43.74M	n/a	-43.02M	-101.77M
Sales Maturities Of Investments	n/a	40.24M	40M	34.99M	34.99M	74.75M
Other Investing Acitivies	n/a	n/a	n/a	n/a	4.55M	n/a
Investing Cash Flow	-696K	4.88M	-6M	34.46M	34.46M	-27.41M
Debt Repayment	9.17M	38.17M	n/a	102.72M	n/a	69.75M
Common Stock Repurchased	-10.88M	-3.73M	-1.01M	-468K	-534K	-63K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.73M	-604K	-4.78M	n/a	-9.51M
Financial Cash Flow	11.39M	36.17M	-1.61M	127.47M	27.25M	126.06M
Net Cash Flow	39.32M	4.07M	-54.64M	59.04M	59.04M	29.67M
Free Cash Flow	27.93M	-37.85M	-49.29M	-103.42M	-103.42M	-96.62M
Adj. Free Cash Flow	5.56M	-56.21M	-60M	-115.58M	-114.8M	-104.89M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-696K	-868K	-2.26M	-524K	-524K	-1.09M
Owner Earnings	28.63M	-36.98M	-47.02M	-102.89M	-102.89M	-95.54M